Arvinas, Inc.ARVNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-5.69%
↓ 174% below average
Average (34q)
7.65%
Historical baseline
Range
High:52.22%
Low:-24.45%
Volatility
1002.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -5.69% |
| Q2 2025 | -24.45% |
| Q1 2025 | 9.00% |
| Q4 2024 | -4.14% |
| Q3 2024 | -7.26% |
| Q2 2024 | 11.15% |
| Q1 2024 | -11.45% |
| Q4 2023 | 10.83% |
| Q3 2023 | -16.92% |
| Q2 2023 | 8.50% |
| Q1 2023 | -3.05% |
| Q4 2022 | 26.84% |
| Q3 2022 | 2.92% |
| Q2 2022 | 17.66% |
| Q1 2022 | 3.56% |
| Q4 2021 | 52.22% |
| Q3 2021 | -5.58% |
| Q2 2021 | 23.21% |
| Q1 2021 | 5.12% |
| Q4 2020 | 10.62% |
| Q3 2020 | 28.17% |
| Q2 2020 | 7.78% |
| Q1 2020 | 6.43% |
| Q4 2019 | 23.07% |
| Q3 2019 | 3.67% |
| Q2 2019 | 12.76% |
| Q1 2019 | -2.55% |
| Q4 2018 | 10.74% |
| Q3 2018 | 27.20% |
| Q2 2018 | 44.71% |
| Q1 2018 | 6.78% |
| Q4 2017 | -7.38% |
| Q3 2017 | -7.68% |
| Q2 2017 | 10.88% |
| Q1 2017 | 0.00% |